Morepen Laboratories Ltd. — Board/Management Information 2020

Jun 22, 2020

Date: 22/06/2020

To,

National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai- 400 051 Dalal Street, Mumbai- 400 001 Tel No: (022) 26598100 - 8114 Phones: 91-22-22721233/4 Fax No: (022) 26598120 Fax: 91-22-2272 3121 Symbol: MOREPENLAB Scrip Code: 500288

Subject: Outcome of the meeting of the Board of Directors of the Company

Dear Sir/ Madam,

This is to inform you that the Board of Directors of the Company, in their meeting held on Monday, 22" June, 2020 (commenced at 12.00 Noon and concluded at 04.15 P.M.), have, inter-alia, considered and approved the:

1. Audited standalone and consolidated financial results of the Company for the quarter and financial year ended 31 March, 2020, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

A copy of the 'Results' along with the Report of the Auditors of the Company, with unmodified opinion, thereon and a declaration to that effect is enclosed herewith. .

• 1. Increase in the authorised share capital of the Company, subject to approval of members.
• 1. Adoption of new set of Memorandum of Association ('MOA') as per the Companies Act, 2013, subject to approval of the members.
• 1. Adoption of new set of Article of Association ('AOA') as per Companies Act, 2013, subject to approval of the members.
• 1. Appointment of Dr. Savita (DIN: 08764773), as an Additional Director designated as Non-Executive, Independent Director, up-to the ensuing Annual General Meeting; and subject to approval of members of the company for a period of 5 years (i.e., from June 22, 2020 to June 21, 2025). , \ i =

In accordance with the circular issued by the Stock Exchanges dated June 20, 2018, we hereby confirm that Dr. Sa vita is not debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or order of any such other authority.

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, as amended, read with SEBI circular no. CIR/CFD/ CMD/4/2015 dated September 9, 2015, brief profile of Dr. Sa vita is enclosed herewith as Annexure-A.

1. Incorporation of two wholly owned subsidiary ('WOS') ofthe companies.

Keeping in view of the continuing constraints due to COVID 19 and the resultant bottlenecks relating to print versions of newspapers; and in accordance with the relaxation given by SEBI vide its circular no. SEBIIHO/CFD/CMD1/CIR/P/2020/48 dated March 26, 2020 read along-with circular no. SEBIIHO/CFD/CMD1/CIR/P/2020179 dated May 12, 2020, the Company will not publish the results in newspapers, as per requirement of Regulation 47 of SEBI (LODR) Regulations, 2015, as amended.

You are requested to take the note of the same in your record.

Thanking you.

Yours faithfully,

For Morepen Laboratories Limited

,1\~~

(Vipul Kumar Srivastava) Company Secretary

Encl. : As above

Morepen Laboratories Limited

Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA Tel. :+91-11-23324443,23712025, E-mail: corporate@morepen.com,Website:www.morepen.com CIN NO. L24231 HP1984PLC006028

Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: plants@morepen.com

		Annexure-A
S. no.	Particular	Disclosure
1.	Reason for change viz., appointment, resignation, removal, death or otherwise;	Appointment
2.	Date of appointment & term of appointment;	Date of appointment- June 22, 2020 Term of appointment- Up-to the date of ensuing Annual General Meeting; and subject to approval of members of the Company for a period of 5 years i.e., till June 21,2025 .
3.	Brief profile	Dr. Savita, is holding a Post Graduate Degree irt Conunerce and has also qualified University Grant Commission ('UGC') National Eligibility Test in year 2007. She was awarded Junior Research Fellowship ('JRF'), which later on elevated to Senior Research Fellowship ('SRF') by UGC and completed her Doctorate Degree (Ph.D.) from
		Department of Commerce, Maharshi Dayanand University, Rohtak, I-Iaryana in the year 2014. She has written sevenil 'Research Papers' on variety of management skills including women entrepreneurship and Income Tax etc., were published in National as well as International journals from time to time.
		She has worked at different positions in the field of education over the last 8 years. She has worked as an Assistant Professor in · the Department of Commerce, Ch. Ranbir Singh University, Jind, Haryana;
		Presently, Dr. Savita associated with the IS Department of Commerce, Gurugram University, Gurugram, Haryana.
4.	Disclosure of relationships between directors	She is not related, either directly or indirectly, with the existing directors of the Company.

Morepen Laboratories Limited

Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA Tel.:+91-11-23324443,23712025, E-mail: corporate@morepen.com,Website:www.morepen.com CIN NO. L24231 HP1984PLC006028

Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: plants@morepen.com